abstract |
The present invention relates to crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3- (methylamino)propoxy]phenyl}-N-[(1S)-2,2,2- trifluoro- 1 - methylethyl][l,2,4]triazolo[l,5-a]pyrimidin-7-amine salts; processes for the production thereof; pharmaceutical compositions thereof; and methods for inhibiting tumor growth therewith. |